All patients were tested HER-2/neu positive by IHC or FISH analyses, and six patients had endocrine dependent disease (luminal B / Her2/neu; four patients had estrogen/progesterone receptor positive cancer, one patient estrogen receptor positive/progesterone receptor negative and one patient estrogen receptor negative/progesterone receptor positive). The gene discussed is PGR; the disease is cancer.